# Mechanosensitive Ion Channel PIEZO1 Suppresses BMP2‐Induced Ossification of the Annulus Fibrosus Cells

**Authors:** Hisakazu Shitozawa, Ryo Nakamichi, Aki Yoshida, Masataka Ueda, Taichi Saito, Koji Uotani, Yoshiaki Oda, Ryo Takatori, Kazutaka Yamashita, Toshifumi Ozaki

PMC · DOI: 10.1002/jsp2.70168 · JOR Spine · 2026-03-03

## TL;DR

PIEZO1, a mechanosensitive ion channel, suppresses bone-like changes in disc cells under low mechanical stress, offering a potential target for treating disc degeneration.

## Contribution

PIEZO1 is shown to suppress BMP2-induced osteogenesis in annulus fibrosus cells via calcineurin-mediated inhibition of BMP signaling.

## Key findings

- Low-strain cyclic tensile strain suppresses osteogenic marker expression in annulus fibrosus cells.
- PIEZO1 activation inhibits BMP2-induced osteogenesis and p-Smad1/5/9 nuclear translocation.
- Transcriptomic analysis reveals enrichment of ossification and calcineurin signaling pathways in rat annulus fibrosus cells.

## Abstract

Major cause of low‐back pain is intervertebral disc degeneration (IVDD), with mechanical stress playing a crucial role in its progression. A mechanosensitive ion channel, PIEZO1, is involved in various musculoskeletal tissues, but its role in the annulus fibrosus (AF) remains unclear. This study aimed to elucidate the function of PIEZO1 in AF cells under mechanical stimulation.

Primary rat AF cells were subjected to cyclic tensile strain (CTS) at low (2%) and high (12%) strain levels to investigate strain‐dependent effects on osteogenic gene expression. We evaluated the effects of Piezo1, Piezo2, and Trpv4 knockdown by RNA interference to identify the upstream mechanotransducer. Furthermore, PIEZO1 was activated using the agonist Yoda1, followed by RNA‐sequencing analysis and evaluation of its effects on BMP2‐induced osteogenesis in rat AF cells. We also examined the effects of Yoda1 in primary human AF cells.

Low‐strain CTS significantly suppressed osteogenic marker expression, which was not observed with high strain. Piezo1 knockdown reversed this suppression, whereas Piezo2 and Trpv4 had no effect. Piezo1 activation by Yoda1 produced similar anti‐osteogenic effects in both rat and human AF cells. RNA sequencing revealed the enrichment of ossification and calcineurin signaling pathways in rat cells. Furthermore, Piezo1 activation inhibited BMP2‐induced osteogenesis and nuclear translocation of p‐Smad1/5/9.

Piezo1 maintains AF cell homeostasis under mechanical stress by suppressing osteogenic changes via calcineurin‐mediated inhibition of BMP signaling, which may represent a novel therapeutic target for IVDD.

This study aimed to elucidate the function of PIEZO1in AF cells under mechanical stimulation. Low‐magnitude cyclictensile strain (CTS, 2%) suppressed osteogenic marker expression. Pharmacological activation of PIEZO1 using Yoda1 mimics the effects oflow‐strain CTS. Transcriptomic analysis revealed enrichment of ossification‐relatedand calcineurin signaling pathways. PIEZO1 activation inhibits BMP2‐inducedosteogenesis and nuclear translocation of p‐Smad1/5/9, thereby maintaining AFcell homeostasis under physiological mechanical stress.

## Linked entities

- **Genes:** PIEZO1 (piezo type mechanosensitive ion channel component 1 (Er blood group)) [NCBI Gene 9780], PIEZO1 (piezo type mechanosensitive ion channel component 1 (Er blood group)) [NCBI Gene 9780], PIEZO2 (piezo type mechanosensitive ion channel component 2) [NCBI Gene 63895], TRPV4 (transient receptor potential cation channel subfamily V member 4) [NCBI Gene 59341], BMP2 (bone morphogenetic protein 2) [NCBI Gene 650]
- **Chemicals:** Yoda1 (PubChem CID 2746822)
- **Diseases:** intervertebral disc degeneration (MONDO:0011385)
- **Species:** Rattus norvegicus (taxon 10116), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, TRPA1 (transient receptor potential cation channel subfamily A member 1) [NCBI Gene 8989] {aka ANKTM1, FEPS, FEPS1, p120}, Piezo2 (piezo-type mechanosensitive ion channel component 2) [NCBI Gene 307380] {aka Fam38b, RGD1306866}, ACAN (aggrecan) [NCBI Gene 176] {aka AGC1, AGCAN, CSPG1, CSPGCP, MSK16, SEDK}, Trpv4 (transient receptor potential cation channel, subfamily V, member 4) [NCBI Gene 66026] {aka Otrpc4, Vroac}, Piezo1 (piezo-type mechanosensitive ion channel component 1) [NCBI Gene 361430] {aka Fam38a, Mib}, DLX5 (distal-less homeobox 5) [NCBI Gene 1749] {aka SHFM1, SHFM1D}, TRPM8 (transient receptor potential cation channel subfamily M member 8) [NCBI Gene 79054] {aka LTRPC6, LTrpC-6, TRPP8, trp-p8}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, TNMD (tenomodulin) [NCBI Gene 64102] {aka BRICD4, CHM1L, TEM}, Runx2 (RUNX family transcription factor 2) [NCBI Gene 367218] {aka CBF-alpha-1, Cbfa1, OSF-2}, Sp7 (Sp7 transcription factor) [NCBI Gene 300260] {aka Osx}, BGLAP (bone gamma-carboxyglutamate protein) [NCBI Gene 632] {aka BGP, OC, OCN}, Piezo1 (piezo-type mechanosensitive ion channel component 1) [NCBI Gene 234839] {aka 9630020g22, Fam38a, mKIAA0233}, UTRN (utrophin) [NCBI Gene 7402] {aka DMDL, DRP, DRP1}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, SPP1 (secreted phosphoprotein 1) [NCBI Gene 6696] {aka BNSP, BSPI, ETA-1, OPN}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CAPN1 (calpain 1) [NCBI Gene 823] {aka CANP, CANP1, CANPL1, SPG76, muCANP, muCL}, CAMK2G (calcium/calmodulin dependent protein kinase II gamma) [NCBI Gene 818] {aka CAMK, CAMK-II, CAMKG, MRD59}, MKX (mohawk homeobox) [NCBI Gene 283078] {aka C10orf48, IFRX, IRXL1}, CAV1 (caveolin 1) [NCBI Gene 857] {aka BSCL3, CGL3, LCCNS, MSTP085, PPH3, VIP21}, SCX (scleraxis bHLH transcription factor) [NCBI Gene 642658] {aka SCXA, SCXB, bHLHa48}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, Pdlim3 (PDZ and LIM domain 3) [NCBI Gene 114108] {aka Actn2lp, Alp}, KCNK4 (potassium two pore domain channel subfamily K member 4) [NCBI Gene 50801] {aka FHEIG, K2p4.1, TRAAK, TRAAK1}, COL2A1 (collagen type II alpha 1 chain) [NCBI Gene 1280] {aka ACG2, ANFH, ANFH1, AOM, COL11A3, EDMMD}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 29373], Trpv4 (transient receptor potential cation channel, subfamily V, member 4) [NCBI Gene 63873] {aka 0610033B08Rik, OTRPC4, Trp12, VR-OAC, VRL-2, VROAC}, FMOD (fibromodulin) [NCBI Gene 2331] {aka FM, SLRR2E}, COX2 (COXII) [NCBI Gene 26198] {aka COII}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, PIEZO1 (piezo type mechanosensitive ion channel component 1 (Er blood group)) [NCBI Gene 9780] {aka DHS, ER, FAM38A, LMPH3, LMPHM6, Mib}, CALM1 (calmodulin 1) [NCBI Gene 801] {aka CALML2, CAM2, CAM3, CAMB, CAMC, CAMI}, PIEZO2 (piezo type mechanosensitive ion channel component 2) [NCBI Gene 63895] {aka C18orf30, C18orf58, DA3, DA5, DAIPT, FAM38B}, TRPV4 (transient receptor potential cation channel subfamily V member 4) [NCBI Gene 59341] {aka BCYM3, CMT2C, HMSN2C, OTRPC4, SMAL, SPSMA}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, KCNK2 (potassium two pore domain channel subfamily K member 2) [NCBI Gene 3776] {aka K2p2.1, TPKC1, TREK, TREK-1, TREK1, hTREK-1c}, ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}, RUNX2 (RUNX family transcription factor 2) [NCBI Gene 860] {aka AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD}, SMAD4 (SMAD family member 4) [NCBI Gene 4089] {aka DPC4, JIP, MADH4, MYHRS}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, BMP2 (bone morphogenetic protein 2) [NCBI Gene 650] {aka BDA2, BMP2A, SSFSC, SSFSC1}, SP7 (Sp7 transcription factor) [NCBI Gene 121340] {aka OI11, OI12, OSX, osterix}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, Piezo2 (piezo-type mechanosensitive ion channel component 2) [NCBI Gene 667742] {aka 5930434P17, 9030411M15Rik, 9430028L06Rik, Fam38b, Fam38b2}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** ossification (MESH:C562735), IVD (MESH:C535531), endplate calcification (MESH:C566415), necrosis (MESH:D009336), AF (OMIM:614822), depression (MESH:D003866), IVDD (MESH:D055959), inflammatory cytokines (MESH:D000080424), calcification (MESH:D002114), mitochondrial dysfunction (MESH:D028361), AIS (OMIM:181800), inflammation (MESH:D007249), LBP (MESH:D017116), CTS (MESH:D013180), ectopic ossification (MESH:D009999), obesity (MESH:D009765)
- **Chemicals:** Lipofectamine (MESH:C086724), Ionomycin (MESH:D015759), CsA (MESH:D016572), Yoda1 (MESH:C000708435), BEC-010 (-), Alizarin Red (MESH:C010078), Calcium (MESH:D002118), DMSO (MESH:D004121), CO2 (MESH:D002245), PDMS (MESH:C013830), phosphate (MESH:D010710), HCl (MESH:D006851), prostaglandin E2 (MESH:D015232), water (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** T9310A, serine/threonine
- **Cell lines:** STEM00015 — Homo sapiens (Human), Parkinson disease, Transformed cell line (CVCL_4E79), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12954436/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12954436/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12954436/full.md

---
Source: https://tomesphere.com/paper/PMC12954436